Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does GEMCITABINE Cause Left ventricular dysfunction? 53 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 53 reports of Left ventricular dysfunction have been filed in association with GEMCITABINE (Gemcitabine). This represents 0.2% of all adverse event reports for GEMCITABINE.

53
Reports of Left ventricular dysfunction with GEMCITABINE
0.2%
of all GEMCITABINE reports
6
Deaths
15
Hospitalizations

How Dangerous Is Left ventricular dysfunction From GEMCITABINE?

Of the 53 reports, 6 (11.3%) resulted in death, 15 (28.3%) required hospitalization, and 10 (18.9%) were considered life-threatening.

Is Left ventricular dysfunction Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for GEMCITABINE. However, 53 reports have been filed with the FAERS database.

What Other Side Effects Does GEMCITABINE Cause?

Off label use (3,319) Disease progression (3,123) Thrombocytopenia (2,320) Drug ineffective (2,003) Malignant neoplasm progression (1,962) Neutropenia (1,892) Anaemia (1,745) Pyrexia (1,511) Nausea (1,336) Myelosuppression (1,197)

What Other Drugs Cause Left ventricular dysfunction?

DOXORUBICIN (430) CYCLOPHOSPHAMIDE (426) TRASTUZUMAB (401) CLOZAPINE (231) SACUBITRIL\VALSARTAN (231) BISOPROLOL (225) PERTUZUMAB (207) RITUXIMAB (202) DOCETAXEL (199) VINCRISTINE (193)

Which GEMCITABINE Alternatives Have Lower Left ventricular dysfunction Risk?

GEMCITABINE vs GEMCITABINE\GEMCITABINE GEMCITABINE vs GEMFIBROZIL GEMCITABINE vs GEMTUZUMAB OZOGAMICIN GEMCITABINE vs GEMZAR GEMCITABINE vs GENTAMICIN

Related Pages

GEMCITABINE Full Profile All Left ventricular dysfunction Reports All Drugs Causing Left ventricular dysfunction GEMCITABINE Demographics